Ura N, Shimamoto K, Nomura N, Aoyama T, Iwata M, Takagawa Y, Iimura O
Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.
Clin Exp Hypertens. 1995 Nov;17(8):1183-96. doi: 10.3109/10641969509037403.
To further investigate the mechanisms of renal effects of neutral endopeptidase 24.11 (NEP) inhibition, we employed a specific NEP inhibitor, UK 73967 (UK), with or without a specific kinin receptor antagonist, Hoe 140 (Hoe), or nitric oxide (NO) synthase inhibitor, N-monomethyl-L-arginine (L-NMMA), in Sprague-Dawley rats, and evaluated the urinary NEP, kinins, cGMP and plasma atrial natriuretic peptide (ANP). None of the variables changed with vehicle injection. After injection of UK, NEP decreased significantly and urinary kinins, cGMP, urine volume (UV) and urinary sodium excretion (UNaV) increased significantly. Injected Hoe canceled the increase in UV and UNaV induced by UK. Plasma ANP did not show any difference between vehicle and UK groups. With a pretreatment of L-NMMA, injected UK decreased NEP and increased kinins, while urinary cGMP, UV and UNaV did not increase. In conclusion, augmented kinins may play an important role in the renal water-sodium metabolism by NEP inhibition, and NO may contribute to the kinins' action on this mechanism, while ANP may not contribute to it, at least in normotensive rats. Moreover, changes in urinary cGMP do not reflect the changes in plasma ANP, but rather, those in NO under this condition.
为了进一步研究中性内肽酶24.11(NEP)抑制作用的肾脏效应机制,我们在Sprague-Dawley大鼠中使用了特异性NEP抑制剂UK 73967(UK),联合或不联合特异性激肽受体拮抗剂Hoe 140(Hoe)或一氧化氮(NO)合酶抑制剂N-单甲基-L-精氨酸(L-NMMA),并评估了尿NEP、激肽、环磷酸鸟苷(cGMP)和血浆心钠素(ANP)。注射赋形剂后,所有变量均无变化。注射UK后,NEP显著降低,尿激肽、cGMP、尿量(UV)和尿钠排泄(UNaV)显著增加。注射Hoe可消除UK诱导的UV和UNaV增加。赋形剂组和UK组之间血浆ANP无差异。预先给予L-NMMA后,注射UK可降低NEP并增加激肽,但尿cGMP、UV和UNaV并未增加。总之,激肽增加可能在NEP抑制引起的肾脏水钠代谢中起重要作用,NO可能参与激肽在此机制中的作用,而ANP可能不参与,至少在正常血压大鼠中如此。此外,尿cGMP的变化并不反映血浆ANP的变化,而是反映在此条件下NO的变化。